Medicare prescription drug plan formulary restrictions after postmarket FDA black box warnings

Michael T. Solotke, Joseph S. Ross, Nilay D. Shah, Pinar Karaca-Mandic, Sanket S. Dhruva

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Medicare prescription drug plan formulary restrictions after postmarket FDA black box warnings'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Social Sciences